Безопасность и риск фармакотерапии is a peer-reviewed russian-language open-access journal published by Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» in Russian Federation, operating under an open-access model since 2015. The journal covers Therapeutics. Pharmacology.
Authors publish in Безопасность и риск фармакотерапии without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, Безопасность и риск фармакотерапии has published 282 articles. Articles are minted with DOIs through the prefix 10.30895. All submissions undergo plagiarism screening before peer review.
Keywords
drug safety, undesirable side reactions, signals, risks of pharmacotherapy, pharmacovigilance
At a glance
- Country
- Russian Federation
- Primary language
- Russian
- License
- CC BY, Publisher's own license
- Peer review
- Double anonymous peer review
- OA since
- 2015
- Review time
- 12 weeks
- DOI prefix
10.30895- Plagiarism check
- Yes
ISSN
- 2312-7821
- electronic
- 2619-1164
Frequently asked questions
Is Безопасность и риск фармакотерапии peer-reviewed?
Does Безопасность и риск фармакотерапии charge an article processing charge (APC)?
What subjects does Безопасность и риск фармакотерапии publish?
What languages does Безопасность и риск фармакотерапии accept?
What is the ISSN of Безопасность и риск фармакотерапии?
2312-7821 (print) · 2619-1164 (electronic).